GENE ONLINE|News &
Opinion
Blog

Nippon Shinyaku
Asia Pacific APACJapan
$810 Million Turned Into a Rare Disease Revolution with Japan’s Nippon Shinyaku’s and USA’s REGENXBIO’s Partnership
2025-01-21
Trials & Approvals Duchenne Muscular Dystrophy-dmdOrphan Drug Designation
The U.S. FDA Grants Orphan Drug Designation to NS-089/NCNP-02 for the Treatment of DMD
2023-08-17
FDA
Weekly Cover：Foundation Medicine and Chugai Partnership with National Cancer Center
2020-02-18
LATEST
Regeneron Steps In to Rescue 23andMe From Bankruptcy With $256M Acquisition
2025-05-20
Virtual trial shows combo rescue inhaler nearly halves severe asthma attacks
2025-05-20
Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition
2025-05-19
The Fight Against Hard-to-Treat Cancers : Bold Bets on a Multifaceted Approach
2025-05-19
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-19
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
READ MORE
EVENT
2025-05-26
2025 Antibody Therapeutic & Frontiers in Biomedical Sciences Conference
Taipei, Taiwan
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top